Osaic Holdings’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $34.8K | Hold |
15,350
| – | – | ﹤0.01% | 4952 |
|
2025
Q1 | $9.76K | Buy |
15,350
+14,480
| +1,664% | +$9.21K | ﹤0.01% | 5743 |
|
2024
Q4 | $896 | Sell |
870
-30
| -3% | -$31 | ﹤0.01% | 6713 |
|
2024
Q3 | $1.06K | Hold |
900
| – | – | ﹤0.01% | 6633 |
|
2024
Q2 | $1.1K | Buy |
+900
| New | +$1.1K | ﹤0.01% | 6607 |
|
2023
Q3 | – | Sell |
-15,350
| Closed | -$28.6K | – | 7226 |
|
2023
Q2 | $28.6K | Hold |
15,350
| – | – | ﹤0.01% | 5310 |
|
2023
Q1 | $24.6K | Sell |
15,350
-14
| -0.1% | -$22 | ﹤0.01% | 5430 |
|
2022
Q4 | $25K | Hold |
15,364
| – | – | ﹤0.01% | 5405 |
|
2022
Q3 | $22K | Hold |
15,364
| – | – | ﹤0.01% | 5496 |
|
2022
Q2 | $28K | Buy |
15,364
+15,039
| +4,627% | +$27.4K | ﹤0.01% | 5364 |
|
2022
Q1 | $1K | Buy |
325
+311
| +2,221% | +$957 | ﹤0.01% | 6850 |
|
2021
Q4 | $0 | Sell |
14
-1
| -7% | – | ﹤0.01% | 7230 |
|
2021
Q3 | $0 | Sell |
15
-31
| -67% | – | ﹤0.01% | 7124 |
|
2021
Q2 | $0 | Buy |
+46
| New | – | ﹤0.01% | 6937 |
|